Market-Based Drug Fees: IRS Will Release 2011 Estimates In May, Guidance Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The IRS guidance proposes a method for calculating the fees and sets out a timetable for the process in 2011, the program's first year. The guidance also describes what corporate entities are liable for the fees and what branded drugs are covered.Register for our free email digests: